Lauren Biscaldi, MS, Managing Editor

In rural settings, patients and providers are frequently reading from different scripts when it comes to managing these conditions

Cross-practice collaboration is one of the best ways to improve patient outcomes.

OTC guidelines for osteoarthritis have evolved over time.

Your weekly roundup of the latest news from Drug Topics®.

Approval was based on results of the phase 3 OlympiA trial.

Your weekly roundup of the latest news from Drug Topics®.

The AMA objects to pharmacy-based clinics as an access point for COVID-19 treatments.

Script Center kiosks are an ATM and an Amazon locker rolled into one.

Your weekly roundup of the latest news from Drug Topics®.

Multiple pharmaceutical companies are investigating the application of mRNA technology to develop vaccines that treat and prevent multiple conditions, from influenza to cancer and beyond.

With each new technological advance comes a set of potential downsides and a myriad of ethical dilemmas that must be addressed.

COVID-19 updates and news to know as of February 28, 2022.

A look at what’s to come in the March issue of Drug Topics®

Take a look back at our most popular news from February 2022.

Your weekly roundup of the latest news from Drug Topics®.

Cariprazine is already approved to treat schizophrenia and bipolar I in adults.

COVID-19 updates and news to know as of February 21, 2022.

Your weekly roundup of the latest news from Drug Topics®.

NVX-CoV2373 was evaluated in adolescents aged 12 to 17 years.

Your weekly roundup of the latest news from Drug Topics®.

COVID-19 updates and news to know as of February 7, 2022.

A recent episode of Medical World News' Deep Dive shared best practices for caring for transgender patients.

Your weekly roundup of the latest news from Drug Topics®.

A look at what’s to come in the February issue of Drug Topics®.

NVX-CoV2373 is a protein-based COVID-19 vaccine for adults 18 years and older.

COVID-19 updates and news to know as of January 31, 2022.

Take a look back at our most popular news from January 2022.

Further research is needed to determine causation.

The monoclonal antibody was conditionally recommended for the treatment of mild to moderate COVID-19 in patients at high risk of hospitalization.

COVID-19 updates and news to know as of January 17, 2022.